Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2021-09-17 00:00:00 ET · period of report 2021-09-15 · accession 0001237899-21-000022 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-09-17 | 2021-09-15 | REGN | COLES N ANTHONY | Dir | M - OptEx | $365.99 | +11.9K | 12.8K | +1,325% | +$4.37M |
| DM | 2021-09-17 | 2021-09-15 | REGN | COLES N ANTHONY | Dir | S - Sale+OE | $658.98 | -11.9K | 2,981 | -80% | -$7.87M |
| DM | 2021-09-17 | 2021-09-15 | REGN | COLES N ANTHONY | Dir | M - OptEx | $0.00 | -11.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-15 | M | A | 6,909 | $380.95 | 7,811 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-15 | S | D | 1,174 | $664.32 | 902 | D | — | — | (F9) Represents volume-weighted average price of sales of 1,174 shares of Company stock on September 15, 2021 at prices ranging from $664.00 to $664.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price. |
| 3 | Common | Common Stock | 2021-09-15 | S | D | 905 | $663.73 | 2,076 | D | — | — | (F8) Represents volume-weighted average price of sales of 905 shares of Company stock on September 15, 2021 at prices ranging from $663.15 to $663.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price. |
| 4 | Common | Common Stock | 2021-09-15 | M | A | 5,039 | $345.47 | 12,850 | D | — | — | |
| 5 | Common | Common Stock | 2021-09-15 | S | D | 300 | $651.36 | 12,550 | D | — | — | |
| 6 | Common | Common Stock | 2021-09-15 | S | D | 1,101 | $652.95 | 11,449 | D | — | — | (F2) Represents volume-weighted average price of sales of 1,101 shares of Company stock on September 15, 2021 at prices ranging from $652.48 to $652.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price. |
| 7 | Common | Common Stock | 2021-09-15 | S | D | 800 | $653.31 | 10,649 | D | — | — | (F3) Represents volume-weighted average price of sales of 800 shares of Company stock on September 15, 2021 at prices ranging from $653.11 to $653.52. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price. |
| 8 | Common | Common Stock | 2021-09-15 | S | D | 403 | $655.14 | 10,246 | D | — | — | (F4) Represents volume-weighted average price of sales of 403 shares of Company stock on September 15, 2021 at prices ranging from $655.14 to $655.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price. |
| 9 | Common | Common Stock | 2021-09-15 | S | D | 1,400 | $656.48 | 8,846 | D | — | — | (F5) Represents volume-weighted average price of sales of 1,400 shares of Company stock on September 15, 2021 at prices ranging from $656.18 to $656.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price. |
| 10 | Common | Common Stock | 2021-09-15 | S | D | 835 | $657.53 | 8,011 | D | — | — | |
| 11 | Common | Common Stock | 2021-09-15 | S | D | 935 | $658.65 | 7,076 | D | — | — | |
| 12 | Common | Common Stock | 2021-09-15 | S | D | 300 | $659.00 | 6,776 | D | — | — | |
| 13 | Common | Common Stock | 2021-09-15 | S | D | 448 | $660.78 | 6,328 | D | — | — | (F6) Represents volume-weighted average price of sales of 448 shares of Company stock on September 15, 2021 at prices ranging from $660.29 to $660.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price. |
| 14 | Common | Common Stock | 2021-09-15 | S | D | 3,344 | $661.56 | 2,984 | D | — | — | (F7) Represents volume-weighted average price of sales of 3,344 shares of Company stock on September 15, 2021 at prices ranging from $661.02 to $661.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price. |
| 15 | Common | Common Stock | 2021-09-15 | S | D | 3 | $662.55 | 2,981 | D | — | — | |
| 16 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-09-15 | M | D | 6,909 | $0.00 | 0 | D | $380.95 · — to 2028-01-02 | 6,909 Common Stock | (F10) The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. |
| 17 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-09-15 | M | D | 5,039 | $0.00 | 0 | D | $345.47 · — to 2027-01-27 | 5,039 Common Stock | (F10) The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. |